ALLMedicine™ Myeloproliferative Disease Center
Research & Reviews 343 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860011
Clinical Epigenetics; Lehmann U, Stark H et. al.
Feb 5th, 2021 - Patients suffering from the BCR-ABL1-negative myeloproliferative disease prefibrotic primary myelofibrosis (pre-PMF) have a certain risk for progression to myelofibrosis. Accurate risk estimation for this fibrotic progression is of prognostic impo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868273
BMJ Case Reports; Looman KIM, Nuver ME et. al.
Feb 5th, 2021 - A previously healthy 40-year-old man was referred to our emergency department with pruritic skin lesions and dyspnoea. Laboratory investigation revealed hypereosinophilia. Further diagnostic work-up confirmed the diagnosis of idiopathic hypereosin...
https://doi.org/10.1111/scd.12537
Special Care in Dentistry : Official Publication of the A... Hassan FW, Mohd N
Oct 30th, 2020 - Polycythemia rubra vera (PRV) is a myeloproliferative disease, which is characterized by the proliferation of all three major hematopoietic groups (erythrocytes, leucocytes and platelets). This hematological condition presented with different clin...
https://doi.org/10.3324/haematol.2020.250969
Haematologica Ong J, Lin JI et. al.
Jun 3rd, 2020 - Clinical acceleration of JAK2 p.V617F driven myeloproliferative disease due to an uncommon homozygous MPL p.Y591D mutation.|2020|Ong J,Lin JI,Mitchell H,Morgan S,Perkins AC,|
https://doi.org/10.1182/blood.2019003910
Blood He H, Xu P et. al.
Apr 18th, 2020 - Hematopoietic stem cell (HSC) aging correlates with an increasing risk of myeloproliferative disease and immunosenescence. In this study, we show that aging-related inflammation promotes HSC aging through tumor necrosis factor-α (TNF-α)→ERK→ETS1→i...
Guidelines 2 results
http://www.jnccn.org/content/15/10/1193.full
Mesa, R.,et al
Sep 30th, 2017 - Myeloproliferative neoplasms (MPNs) are a group of heterogeneous disorders of the hematopoietic system that include myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia (ET). PV and ET are characterized by significant thromboh.
http://www.jnccn.org/content/14/12/1572.full
Mesa, R.,et al
Nov 30th, 2016 - Myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia (ET) are a group of heterogeneous disorders of the hematopoietic system collectively known as Philadelphia chromosome–negative myeloproliferative neoplasms (MPNs). The diagn.
Clinicaltrials.gov 353 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860011
Clinical Epigenetics; Lehmann U, Stark H et. al.
Feb 5th, 2021 - Patients suffering from the BCR-ABL1-negative myeloproliferative disease prefibrotic primary myelofibrosis (pre-PMF) have a certain risk for progression to myelofibrosis. Accurate risk estimation for this fibrotic progression is of prognostic impo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868273
BMJ Case Reports; Looman KIM, Nuver ME et. al.
Feb 5th, 2021 - A previously healthy 40-year-old man was referred to our emergency department with pruritic skin lesions and dyspnoea. Laboratory investigation revealed hypereosinophilia. Further diagnostic work-up confirmed the diagnosis of idiopathic hypereosin...
https://doi.org/10.1111/scd.12537
Special Care in Dentistry : Official Publication of the A... Hassan FW, Mohd N
Oct 30th, 2020 - Polycythemia rubra vera (PRV) is a myeloproliferative disease, which is characterized by the proliferation of all three major hematopoietic groups (erythrocytes, leucocytes and platelets). This hematological condition presented with different clin...
https://doi.org/10.3324/haematol.2020.250969
Haematologica Ong J, Lin JI et. al.
Jun 3rd, 2020 - Clinical acceleration of JAK2 p.V617F driven myeloproliferative disease due to an uncommon homozygous MPL p.Y591D mutation.|2020|Ong J,Lin JI,Mitchell H,Morgan S,Perkins AC,|
https://doi.org/10.1182/blood.2019003910
Blood He H, Xu P et. al.
Apr 18th, 2020 - Hematopoietic stem cell (HSC) aging correlates with an increasing risk of myeloproliferative disease and immunosenescence. In this study, we show that aging-related inflammation promotes HSC aging through tumor necrosis factor-α (TNF-α)→ERK→ETS1→i...
News 4 results
https://www.mdedge.com/hematology-oncology/article/187211/transplantation/switch-may-increase-supply-hscs-cord-blood
HT Staff
Jul 15th, 2016 - Cord blood donation Photo courtesy of NHS Researchers have discovered a genetic switch that could increase the supply of hematopoietic stem cells (HSCs) derived from cord blood, according to a paper published in Cell Stem Cell. However, experiment.
https://www.medpagetoday.com/hematologyoncology/leukemia/28127
Aug 20th, 2011 - Action Points Note that chronic myeloid leukemia is a myeloproliferative disease characterized by a chromosomal translocation, which leads to production of the BCR–ABL oncoprotein, an active tyrosine kinase. Tyrosine kinase inhibitor (TKI) imatini...
https://www.medscape.com/viewarticle/558906_1
Abstract and Introduction Abstract The point mutation 1849 (GAET) V617F in the JAK2gene occurs at high frequency in several chronic myeloproliferative diseases. Although a number of V617F mutation detection methods have been described, few are rea...
https://www.medscape.com/viewarticle/558906
Abstract and Introduction Abstract The point mutation 1849 (GAET) V617F in the JAK2gene occurs at high frequency in several chronic myeloproliferative diseases. Although a number of V617F mutation detection methods have been described, few are rea...